刘文虎,王仕宝,刘毅. 4-(2-乙酰氧基苯甲酰氨基)丁酰胺基杂环化合物的合成及活性研究J. 药学学报, 2012,47(11): 1496-1502.
引用本文: 刘文虎,王仕宝,刘毅. 4-(2-乙酰氧基苯甲酰氨基)丁酰胺基杂环化合物的合成及活性研究J. 药学学报, 2012,47(11): 1496-1502.
LIU Wen-hu,WANG Shi-bao,LIU Yi. Synthesis and activities of 4-(2-acetoxybenzoylamino) butyramide heterocyclic compoundsJ. 药学学报, 2012,47(11): 1496-1502.
Citation: LIU Wen-hu,WANG Shi-bao,LIU Yi. Synthesis and activities of 4-(2-acetoxybenzoylamino) butyramide heterocyclic compoundsJ. 药学学报, 2012,47(11): 1496-1502.

4-(2-乙酰氧基苯甲酰氨基)丁酰胺基杂环化合物的合成及活性研究

Synthesis and activities of 4-(2-acetoxybenzoylamino) butyramide heterocyclic compounds

  • 摘要:

    前期研究发现, 4-(2-乙酰氧基苯甲酰氨基) 丁酰胺类化合物具有较好的抗癫痫活性。据此, 本文以中 γ-氨基丁酸受体 (γ-aminobutyric acid receptor, GABAR) 为靶点, 设计合成了系列全新结构的4-(2-乙酰氧基苯甲酰氨基) 丁酰胺基杂环类化合物 (5a5n), 希望完善此类化合物的构效关系及提高其抗癫痫活性。化合物结 构经1H MNRESI-MS及元素分析确证。体内药效筛选结果表明, 化合物5f5i5n4-AP致癫痫小鼠具有良好抗癫痫活性 (ED50值为0.313 70.360 4 mmol·kg−1)

     

    Abstract:

    It has been demonstrated by our previous research that 4-(2-acetoxybenzoylamino) butyramide derivatives exhibited good antiepileptic activities.  In this paper, to explore the SAR and improve the antiepileptic activities of these derivatives, a series of novel 4-(2-acetoxybenzoylamino) butyramide heterocyclic compounds (5a5n) were synthesized and biologically evaluated.  Their structures were confirmed by 1H MNR, ESI-MS and elemental analysis.  Pharmacological test in vivo showed that target compounds (5f, 5i5n) displayed strong antiepileptic activities on 4-AP induced epilepsy in mice with ED50 values ranging from 0.313 7 to 0.360 4 mmol·kg−1.

     

/

返回文章
返回